Factors Related to Postoperative Mortality in Lung Transplantation for Emphysema

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3317-3322

  Ferrer, J ^a   Rodriguez, E ^a   Roman, A ^a   Bravo, C ^a   Roldan, J ^a   Hermosilla, E ^a   Canela, M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CARDIOPULMONARY BYPASS; DEMOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEMATOTHORAX; HUMAN; ISCHEMIA; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY;

ADULT; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; POSTOPERATIVE COMPLICATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 37049017066     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.09.006     Document Type: Article

References (47)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990- 2020: Global Burden of Disease Study. Lancet 349 (1997) 1498
2. Anto J.M., Vermeire P., Vestbo J., et al. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 17 (2001) 982
3. Sobradillo V., Miravitlles M., Gabriel R., et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological Study. Chest 118 (2000) 981
4. Fletcher C.M., Peto R., Tinker C.M., et al. The Natural History of Chronic Bronchitis and Emphysema (1976), Oxford University Press, Oxford
5. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 93 (1980) 391
6. Medical Research Council Working Party?. Long term domiiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1 (1981) 681
7. Trulock E.P., Edwards L.B., Taylor D.O., et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report- 2003. J Heart Lung Transplant 22 (2003) 625
8. Low D.E., Trulock E.P., Kaiser L.R., et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovas Surg 103 (1992) 1119
9. Connors Jr. A.F., Dawson N.V., Thomas C., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risk of Treatments). Am J Respir Crit Care Med 154 (1996) 959
10. Chu C.M., Chan V.L., Lin A.W.N., et al. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59 (2004) 1020
11. Hosenpud J.D., Novick R.J., Bennett L.E., et al. The Registry of the International Society for Heart and Lung Transplantation thirteenth official report 1996. J Heart Lung Transplant 15 (1996) 655
12. Geertsma A., Ten Vergert E.M., Bonsel G.J., et al. Does lung transplantation prolong life?. A comparison of survival with or without transplantation. J Heart Lung Transplant 17 (1998) 511
13. Charman S.C., Sharples L.D., McNeil K.D., et al. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 21 (2002) 226
14. Snell G.I., Rabinov M., Griffiths A., et al. Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation. J Heart Lung Transplant 15 (1996) 160
15. Grady K.L., White-Williams C., Naftel D., et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant 18 (1999) 750
16. Fiser S.M., Kron I.L., Long S.M., et al. Influence of graft isquemic time on outcomes following lung transplantation. J Heart Lung Transplant 20 (2001) 1291
17. Gammie J.S., Stukus D.R., Pham S.M., et al. Effect of isquemic time on survival in clinical lung transplantation. Ann Thorac Surg 68 (1999) 2015 discussion 2019
18. Aeba R., Griffith B.P., Kormos R.L., et al. Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg 57 (1994) 715
19. Sekine Y., Waddelll T.K., Matte-Martyn A., et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 23 (2004) 96
20. De Boer W.J., Hepkema B.G., Loef B.G., et al. Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients. Transplantation 73 (2002) 1621
21. Szeto W.Y., Kreisel D., Karakousis G.C., et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg 124 (2002) 241
22. Cassivi S.D., Meyers B.F., Battafarano R.J., et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 74 (2002) 1663 discussion 1669
23. Barbera J.A., Peces-Barba G., Agusti A.G., et al. Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Arch Bronconeumol 37 (2001) 297
24. Patterson G.A., Cooper J.D., Goldman B., et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 45 (1988) 626
25. Charlsson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373
26. Anthonisen N.R., Manfreda J., Warren C.P., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196
27. Goldman L., Hashimoto B., Cook E.F., et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64 (1981) 1227
28. Opelz G., and Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The collaborative transplant study. N Engl J Med 330 (1994) 816
29. Gomez F.J., Planas A., Ussetti P., et al. Factores pronósticos de morbimortalidad en el postoperatorio inmediato del trasplante pulmonar. Arch Bronconeumol 39 (2003) 353
30. Smits J.M.A., Mertens B.J.A., van Houwelingen H.C., et al. Predictors of lung transplant survival in Eurotransplant. Am J Transpl 3 (2003) 1400
31. Hertz M.I., Taylor D.O., Trulock E.P., et al. The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Official Report-2002. J Heart Lung Transplant 21 (2002) 950
32. Novick R.J., Bennett L.E., Meyer D.M., et al. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 18 (1999) 425
33. Thabut G., Mal H., Cerrina J., et al. Graft ischemic time and outcome of lung transplantation. Am J Respir Crit Care Med 171 (2005) 786
34. Mc Rae K. Con: lung transplantation should not be routinely performed with cardiopulmonary bypass. J Card Vasc Anest 14 (2000) 746
35. Anastasios N., Triantafillou M.D., Michael K., et al. Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults. Ann Thorac Surg 57 (1994) 1248
36. De Hoyos A., De Majo W., Snell G., et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg 106 (1993) 787
37. Ferrer J., Roldan J., Roman A., et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant 22 (2003) 1217
38. Stuart R.S., and Baumgartner W.A. Medical complications of lung transplantation. In: Kaye M.P., and O'Connell J.B. (Eds). Heart and Lung Transplantation (1992), Landes Company, Austin 44 2000
39. Judson M.A., Handy J.R., and Sahn S.A. Pleural effusions following lung transplantation. Time course, characteristics, and clinical implications. Chest 109 (1996) 1190
40. Stevens J., Cai J., et al. The effect of age on the association between body-mass index and mortality. Pamuk 0ER. N Engl J Med 338 (1998) 1
41. Landbo C., Prescott E., Lange P., et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856
42. Plochl W., Pezawas L., Artemiou O., et al. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intens Care Med 22 (1996) 1179
43. Snell G.L., Bennetts K., Bartolo J., et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant 17 (1998) 1097
44. Madill J., Gutierrez C., Grossman J., et al. Toronto Lung Transplant Program: nutritional assessment of the lung transplant patients: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant 20 (2001) 288
45. Janashi W.F., Anton S.D., Rodriguez J.R., et al. Impact of body weight on long-term survival after lung transplantation. Chest 121 (2002) 401
46. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005
47. Ussetti P., and Laporta R. Predicting outcomes in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2309